Related Experiment Video

Updated: Dec 21, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.3K

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions

Liuliu Gao1, Hua Xu1, Qi Ye1

  • 1Department of Clinical Pharmacy, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Pharmacology
|May 21, 2020
PubMed

Insights

This study determined teicoplanin population pharmacokinetics in Chinese children. Recommended individualized dosing regimens for pediatric patients with varying renal functions optimize treatment outcomes.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Nephrology

Background:

  • Teicoplanin is an important antibiotic for treating Gram-positive bacterial infections.
  • Optimizing teicoplanin dosing in pediatric populations is crucial due to varying pharmacokinetic profiles.
  • Renal function significantly impacts drug clearance and requires dosage adjustments.

Purpose of the Study:

  • To investigate the population pharmacokinetics (PK) of teicoplanin in Chinese children.
  • To establish appropriate teicoplanin dosing regimens for pediatric patients with different renal functions.
  • To ensure therapeutic efficacy and minimize toxicity through individualized dosing.

Main Methods:

  • Prospective pharmacokinetic study in children aged 0-10 years with varying renal functions.
  • Development of a population PK model for teicoplanin using Non-linear Mixed Effects (NLME).
  • Simulation-based prediction of individualized optimal dosage regimens.

Main Results:

  • Optimal teicoplanin dosing regimens were predicted based on population PK simulations to achieve target trough levels (10-30 mg/L).
  • Children with moderate renal insufficiency: 6 mg/kg q12h (3 loading doses) followed by 5 mg/kg qd.
  • Children with mild renal insufficiency: 12 mg/kg q12h (3 loading doses) followed by 8 mg/kg qd.
  • Children with normal/augmented renal function: 12 mg/kg q12h (3 loading doses) followed by 10 mg/kg qd.

Conclusions:

  • This is the first study on teicoplanin population pharmacokinetics in Chinese children with diverse renal functions.
  • Individualized teicoplanin dosing regimens are recommended for different renal function groups.
  • The proposed regimens aim to optimize teicoplanin therapy in pediatric patients.
Abstract

Keywords:
Chinese childrenchildren with different renal functionsdosing optimizationpopulation pharmacokineticsteicoplanin

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.0K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
147
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
126
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
167
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
143